FREDUN PHARMACEUTICALS
Quarterly Results Analysis [Mar2026]
FREDUN PHARMACEUTICALS Quarterly Results
| Consolidated | Mar2026 UnAudited |
Dec2025 Audited |
Sep2025 Audited |
Jun2025 UnAudited |
Mar2025 UnAudited |
Dec2024 UnAudited |
|---|---|---|---|---|---|---|
| Revenues | ₹213 Cr | ₹161 Cr | ₹145 Cr | ₹120 Cr | ₹167 Cr | ₹0 Cr |
| Expenses | ₹184 Cr | ₹135 Cr | ₹123 Cr | ₹103 Cr | ₹150 Cr | ₹0 Cr |
| Operating Income | ₹29 Cr | ₹26 Cr | ₹22 Cr | ₹17 Cr | ₹17 Cr | ₹0 Cr |
| Other Income | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Interest | ₹14 Cr | ₹11 Cr | ₹8 Cr | ₹7 Cr | ₹8 Cr | ₹0 Cr |
| Depreciation | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹0 Cr |
| Profit Before Tax | ₹11 Cr | ₹14 Cr | ₹13 Cr | ₹9 Cr | ₹7 Cr | ₹0 Cr |
| Profit After Tax | ₹11 Cr | ₹10 Cr | ₹9 Cr | ₹7 Cr | ₹6 Cr | ₹0 Cr |
| EPS | ₹19.70 | ₹19.53 | ₹19.97 | ₹14.33 | ₹12.71 | ₹0.00 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| FREDUN PHARMACEUTICALS | -3.7% | -6.3% | 198.3% |
| SUN PHARMACEUTICAL INDUSTRIES | -0.7% | -3.6% | 6% |
| DIVIS LABORATORIES | 1.1% | -1.2% | -0.3% |
| TORRENT PHARMACEUTICALS | 1.6% | 1.4% | 36.7% |
| CIPLA | 0.7% | 2.6% | -4.6% |
| DR REDDYS LABORATORIES | -0.9% | -2.5% | 1.2% |
| MANKIND PHARMA | 0.7% | -1.1% | -4.8% |
| LUPIN | 0.4% | -7.1% | 14.8% |
| ZYDUS LIFESCIENCES | -0.2% | 16% | 16.7% |
FREDUN PHARMACEUTICALS Quarterly Revenues
| Revenues | |
|---|---|
| Q-o-Q | 32.40 % |
| Y-o-Y | 27.27 % |
| Quarters | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹213 Cr | 32.40 | |
| Dec2025 | ₹161 Cr | 10.76 | |
| Sep2025 | ₹145 Cr | 21.22 | |
| Jun2025 | ₹120 Cr | -28.41 | |
| Mar2025 | ₹167 Cr | 0 | |
| Dec2024 | ₹0 Cr | - | |
FREDUN PHARMACEUTICALS Quarterly Operating Profit
| Operating Profit | |
|---|---|
| Q-o-Q | 9.68 % |
| Y-o-Y | 67.42 % |
| Quarters | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹29 Cr | 9.68 | |
| Dec2025 | ₹26 Cr | 17.94 | |
| Sep2025 | ₹22 Cr | 31.42 | |
| Jun2025 | ₹17 Cr | -1.51 | |
| Mar2025 | ₹17 Cr | 0 | |
| Dec2024 | ₹0 Cr | - | |
| Operating Margins | |
|---|---|
| Q-o-Q | -17.11 % |
| Y-o-Y | 31.52 % |
| Quarters | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 13.56% | -17.11 | |
| Dec2025 | 16.36% | 6.44 | |
| Sep2025 | 15.37% | 8.39 | |
| Jun2025 | 14.18% | 37.54 | |
| Mar2025 | 10.31% | 0 | |
| Dec2024 | 0% | - | |
FREDUN PHARMACEUTICALS Quarterly Profit After Tax
| Profit After Tax(PAT) | |
|---|---|
| Q-o-Q | 2.88 % |
| Y-o-Y | 79.56 % |
| Quarters | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹11 Cr | 2.88 | |
| Dec2025 | ₹10 Cr | 11.08 | |
| Sep2025 | ₹9 Cr | 39.42 | |
| Jun2025 | ₹7 Cr | 12.69 | |
| Mar2025 | ₹6 Cr | 0 | |
| Dec2024 | ₹0 Cr | - | |
| PAT Margins | |
|---|---|
| Q-o-Q | -22.27 % |
| Y-o-Y | 40.95 % |
| Quarters | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 5.06 % | -22.27 | |
| Dec2025 | 6.51 % | 0.31 | |
| Sep2025 | 6.49 % | 15.07 | |
| Jun2025 | 5.64 % | 57.10 | |
| Mar2025 | 3.59 % | 0 | |
| Dec2024 | 0 % | - | |
FREDUN PHARMACEUTICALS Quarterly Earnings Per Share (EPS)
| EPS | |
|---|---|
| Q-o-Q | 0.87 % |
| Y-o-Y | 55.00 % |
| Quarters | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹19.7 | 0.87 | |
| Dec2025 | ₹19.53 | -2.20 | |
| Sep2025 | ₹19.97 | 39.36 | |
| Jun2025 | ₹14.33 | 12.75 | |
| Mar2025 | ₹12.71 | 0 | |
| Dec2024 | ₹0 | - | |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD